John Leslie Fahey 1924–2014
A golden opportunity
Not too little, not too much—just right! (Better ways to give high dose melphalan)
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia
Superselective intra-arterial umbilical cord blood administration to BM in experimental animals
Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen
The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT
NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD
Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD
Administration of anti-thymocyte globulin: a comparison of two protocols
Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children
Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation
Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma
Bortezomib/bendamustine/dexamethasone induced good PR in refractory relapse post auto-SCT with constitutive RAS activation due to V600E BRAF mutation
High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation
Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas